News - Human Genome Sciences Inc.
2011-12-29 08:30:00
Vertex Pharma (Nasdaq: VRTX), Human Genome Sciences Inc. (Nasdaq: HGSI), Biogen Idec (Nasdaq: BIIB) and Perrigo Company
2011-03-08 07:25:00
A drug for lupus, produced by Human Genome Sciences Inc, is set to get clearance from health regulators, bringing patients the first approved treatment in more than 50 years, and potentially bringing heavy revenue to the company.
2011-03-01 08:00:00
HONG KONG, March 1 /PRNewswire/ - Today, www.WorldStreetFundamentals.com released its industry report highlighting Dendreon Corp. (NASDAQ: DNDN) and Human Genome Sciences, Inc. (NASDAQ: HGSI).